A multicenter Phase I safety study of intratumoral photoactivation of talaporfin sodium in patients with refractory solid tumors.
about
A review of progress in clinical photodynamic therapyPhotodynamic nanomedicine in the treatment of solid tumors: perspectives and challengesTwo-dimensional artificial light-harvesting antennae with predesigned high-order structure and robust photosensitising activityReduction of Endotracheal Tube Biofilms Using Antimicrobial Photodynamic TherapyArt and science of photodynamic therapy.Light delivery over extended time periods enhances the effectiveness of photodynamic therapy.New Monte Carlo model of cylindrical diffusing fibers illustrates axially heterogeneous fluorescence detection: simulation and experimental validation.The use of natural products in colorectal cancer drug discovery.Prostate PDT dosimetry.The Role of Laser Speckle Imaging in Port-Wine Stain Research: Recent Advances and Opportunities.Evaluation of Hydrogel Suppositories for Delivery of 5-Aminolevulinic Acid and Hematoporphyrin Monomethyl Ether to Rectal Tumors.In vivo confocal fluorescence imaging of the intratumor distribution of the photosensitizer mono-L-aspartylchlorin-e6.Photodynamic therapy for treatment of solid tumors--potential and technical challenges.Talaporfin sodium.On the in vivo photochemical rate parameters for PDT reactive oxygen species modeling.Microscopic analysis of the localization of two chlorin-based photosensitizers in OSC19 tumors in the mouse oral cavity.Treatment of canine osseous tumors with photodynamic therapy: a pilot study.Safety Study of Photodynamic Therapy Using Talaporfin Sodium in the Pancreas and Surrounding Tissues in the Syrian Golden Hamster
P2860
Q24535545-10050ACF-6331-4DE5-97EA-16C1C6B58A0CQ26827820-BD1CD948-2B8C-4B30-93DA-8C1DEB4C4449Q28830433-7E453979-EEC6-4311-98DA-CBC3B5C9975EQ30464245-268DF769-366B-4EA1-9BA5-335FAF35A5BAQ33243421-6D0F41B9-DED8-4AE5-AA75-155FD1E8C31EQ33331297-7280FCDC-5CA8-4749-9990-C986397D2D51Q35194376-F3CB0786-5256-4001-A83E-642715B76C80Q35569158-0A8C0056-3631-408C-9E31-F3657B9709AEQ35748396-B0C970B4-115D-4D23-A743-44667CC8926EQ35970012-21C9E468-770F-4779-96B7-87EB0C7B2B6DQ36165888-334C7203-B9E8-4EFC-9847-25AA990239BBQ36640198-F1247BB5-26B3-4CDF-B87E-1ED54E0C2652Q36995497-A7D070E5-28E1-4BB5-A79B-F3D1A6B57170Q37650329-6AE8434F-D392-4369-841E-D2B31FF27336Q38976558-D75E0215-DBDE-470F-A1A8-B5C4D955DDC2Q39033555-338E0360-92D3-495D-ACB9-A3BBE43D4391Q41983616-DE296F51-6F63-4296-96CB-8BA48A8ED51DQ59045167-45B2187A-4F28-42FA-ABDD-B75AFC527925
P2860
A multicenter Phase I safety study of intratumoral photoactivation of talaporfin sodium in patients with refractory solid tumors.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
A multicenter Phase I safety s ...... with refractory solid tumors.
@ast
A multicenter Phase I safety s ...... with refractory solid tumors.
@en
type
label
A multicenter Phase I safety s ...... with refractory solid tumors.
@ast
A multicenter Phase I safety s ...... with refractory solid tumors.
@en
prefLabel
A multicenter Phase I safety s ...... with refractory solid tumors.
@ast
A multicenter Phase I safety s ...... with refractory solid tumors.
@en
P2093
P356
P1433
P1476
A multicenter Phase I safety s ...... with refractory solid tumors.
@en
P2093
Anil K D'Cruz
Anil Singhal
David Fromm
James C Chen
Marko Turić
R Alex Hsi
Robert A Lustig
Rosa Cuenca
Thomas J Vogl
Zdenko Krajina
P304
P356
10.1002/CNCR.11708
P407
P577
2003-10-01T00:00:00Z